Login / Signup

Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study.

Cong ZhuLan YangHao ZiBing-Hui LiQiao HuangMeng-Xin LuXiao-Dong LiXuan-Yi RenHua TaoHankun HuXian-Tao Zeng
Published in: BioMed research international (2022)
HCA probably has an advantage over HC, HCB, and EDD in reducing the hospitalization time, catheterization time, and bladder irrigation time among BPH patients undergoing TUPKP.
Keyphrases
  • benign prostatic hyperplasia
  • patients undergoing
  • lower urinary tract symptoms
  • prostate cancer
  • spinal cord injury
  • randomized controlled trial
  • clinical trial
  • ultrasound guided